Thyrotropin-Releasing Hormone (TRH): A Tracking Guide

Thyrotropin-Releasing Hormone (TRH) is a tripeptide — pyroGlu-His-Pro — produced by the hypothalamus. It is the upstream signal that drives pituitary release of TSH and prolactin. Clinically it has been used as a diagnostic agent (the TRH stimulation test), and there is research literature on TRH in depression, ALS, and traumatic brain injury contexts. Self-experimenter use is rare and the evidence base is genuinely thin.

What it does

TRH binds pituitary thyrotrophs and stimulates TSH release, which in turn raises T4 and T3 production downstream. It also stimulates prolactin release. Beyond the HPT axis, TRH has direct CNS effects: arousal, mood modulation, autonomic activation. The CNS effects are why it shows up in depression and ALS literature.

Typical protocol shape

There is no settled self-experimenter protocol. Reported patterns include:

• Intranasal dosing for CNS-targeted use
• Subcutaneous dosing in some research contexts
• Very short half-life (minutes), so any sustained effect requires repeated dosing or alternate delivery

If you are exploring TRH, the honest framing is that you are running an experiment with limited precedent.

What to track daily

• Time and route of each dose
• Subjective arousal and energy (1 to 10) at multiple points across the day
• Mood (1 to 10)
• Sleep quality and onset latency
• Resting heart rate and blood pressure
• Any signs of thyroid over- or under-activation (heat intolerance, tremor, palpitations, fatigue, cold intolerance)

What to track weekly

• Body weight
• Average resting heart rate
• Menstrual cycle changes if applicable (TRH affects prolactin)
• Galactorrhea is rare but worth noting

Bloodwork worth doing

If you are going to run TRH, you need labs. Without them you are flying blind on the HPT axis:

• TSH, free T4, free T3 at baseline
• Prolactin at baseline
• Re-check at 4 to 6 weeks if you continue
• Reverse T3 if your physician will order it

Single-point TSH after TRH dosing reflects the acute stimulation and is not a useful chronic marker; the chronic question is whether your set point has shifted.

Realistic expectations

TRH is not a "feel-good peptide" with a clean published self-experimenter story. The CNS effects are real but transient. The HPT axis effects are real but can disrupt a previously stable thyroid set point. Expect noise, expect to need labs, and expect to potentially destabilize something that was working.

Common mistakes

• Running TRH without baseline thyroid labs. You will not know what you changed.
• Stacking with thyroid hormone replacement. This is a physician-level decision.
• Chasing acute arousal effects. They fade, and chasing them with more frequent dosing is how people get into trouble.
• Ignoring prolactin. It rises with TRH and can cause real symptoms.

A tracking template

• Pre-cycle: full thyroid panel and prolactin
• Weeks 1 to 4: dose log, daily metrics, weekly weight
• Week 4 or 5: repeat labs
• Decide based on labs and symptoms whether to continue

Safety notes

TRH affects a major endocrine axis. This is not a peptide to self-experiment with casually. Discuss with a physician — ideally an endocrinologist — particularly if you have any thyroid history, are on thyroid medication, are pregnant, or have a pituitary condition.

Peptide IA is an educational and self-tracking tool. Nothing in this post is medical advice. Doses mentioned reflect what is commonly reported in research literature — they are not recommendations. Always consult a qualified physician before starting, changing, or stopping any protocol.